Skip to the page

Data / Form D filings / SurgiBox Inc.

SurgiBox Inc.: Form D filings

SurgiBox Inc., a biotechnology company in Cambridge, MA, filed 4 Form D notices with the SEC between 2022 and 2026. The latest, on September 17, 2026, reports $486,000 sold of a $3 million offering to 9 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
1035 CAMBRIDGE ST. #1, Cambridge, MA, 02141
Phone
(617) 394-8903
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1930227

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Sep 17, 2026New notice$3,000,000$486,000$2,514,0009Mar 19, 2026sec.gov
Aug 8, 2024New notice$1,000,000$167,484$832,51622Jul 18, 2024sec.gov
Aug 24, 2023New notice$749,980$749,98019Aug 10, 2023sec.gov
May 26, 2022New notice$2,000,000$125,000$1,875,0005May 3, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Kelly LaurelExecutive Officer, Director
Sam GoldbergerDirector
Steve EppingerDirector
Mike TeodorescuDirector
Debbie TeodorescuDirector

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Sep 14, 2026 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what SurgiBox Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.